Back to Newsroom announces Pharnext as winner of the Best Life-Sciences IPO France 2016 Award

London (U.K.), Paris (France), January 17, 2017 – Capital Finance International (CFI), a print journal and online resource reporting on business, economics, and finance and Pharnext SA (FR00111911287 – ALPHA), a French biopharmaceutical company developing an advanced portfolio of products in the field of neurodegenerative diseases, announced today that the judges have conferred on Pharnext its Best Life-Sciences IPO France 2016 Award.

Click here to read the full release